Response from Dr.

[Guest guest]

Dear April,

Thanks for your expression of concern about the very limited

research support I am receiving. The real concern ought to be for autistic

children and their families. It is disappointing to me that very few so called

advocates for these children are willing to acknowledge the potential role of

stealth-adapted viruses in causing autism. I used to think it was my

responsibility to convince others of what appeared to me to be pretty obvious.

That is, if autism is epidemic one should suspect an infectious cause. A role

for stealth-adapted viruses was established in double blind culture studies

attested to by well qualified individuals. Yet the data were not acted upon.

When I offered to speak at a local meeting in Los Angeles, I was bluntly told

" You are off message ; " meaning that I was not supporting mercury as the

cause of autism and not advocating expensive laboratory tests or therapies with

kick-backs to those willing to wheel and deal.

As I mentioned in an earlier letter, it is truly

disappointing when a speaker fresh from receiving a standing ovation by

appreciative parents is seen conversing with colleagues on how to franchise a

lucrative scheme for generating exorbitant incomes. I rarely receive requests

from other investigators or patient advocates to help explain stealth-adaptation

or the concept of an alternative (non-mitochondria) pathway of cellular energy.

Conversely my requests for an overview of laboratory results to better

understand how they influence therapy are met with resistance. Similarly, the

actual response rates to the various therapies in terms of hard clinical data

are rarely provided.

I would like to see a vigorous movement among parents of

autistic children to demand that their children and other family members be

tested in Public Health facilities for infectious viruses. Whether they are

called stealth-adapted or something else, it is not difficult to demonstrate

their presence using methods that were published over a decade ago. Some of the

viruses will undoubtedly be shown to have arisen from African green monkey

simian cytomegalovirus. This is consistent with FDA's own data of DNA of this

virus being present in 3 of 8 licensed polio vaccine lots released in the mid

1970s. It also follows the 1972 realization that the monkeys being used to

produce live polio virus vaccine were uniformly infected with simian

cytomegalovirus. In retrospect, the use of freshly cultured monkey kidney cells

to produce polio vaccines may turn out to be the biggest Public Health blunder

of the last century.

Stealth-adaptation of cytomegalovirus and other viruses

is based on the simple concept that the cellular immune system only recognizes

and reacts to relatively few viral components. In the case of human

cytomegalovirus, over 90% of the anti-virus cytotoxic T cells are directed at

only 3 of the nearly 200 different components. Loss or mutation of these

critical components can allow a virus to evade effective immune recognition. A

present day analogy is that of a terrorist who has no insignia or other means of

identification. Like a terrorist, stealth-adapted viruses can still cause a lot

of damage. It is mostly reflected by impaired functioning of the brain which is

especially vulnerable to even limited localized cell damage.

Fortunately, the immune system is not the only defense

humans and animals have against virus infections. From the beginning of the

research, it was apparent that if cultures of stealth-adapted viruses were left

undisturbed, the damaged cells would recover. The recovery process was

attributed to the accumulation of what I termed alternative cellular energy

pigments (ACE pigments). Validation of this approach has come from recently

published studies showing expedited healing of conventional herpes simplex and

herpes zoster viruses and also papillomavirus induced skin lesions by activating

the ACE pathway. I firmly believe that autism will also be amenable to this

type of approach.

ACE related therapies are not dependent upon there being

an underlying virus infection. On the other hand, mobilization of Public Health

resources in support of preventing and treating autism will be more forthcoming

to counter an infectious process. I am open to suggestions and to offers of help

to move the process forward. This has been a productive year in terms of

publications with five peer reviewed articles, four of which are on the web site

www.s3support.com. The article that I look forward to seeing published this

year will be one showing marked clinical benefits in autistic and other

stealth-adapted virus infected children in response to activation of the ACE

pathway. With sufficient support and public awareness, I feel this goal can be

achieved.

Kind regards,

W. , M.D., Ph.D.

e-mail address: S3support@...

DEFINITION * TREATMENT * PREVENTION

Autism is 1 in 150 children today, 1 in 68 families! TAAP (The Autism

Autoimmunity Project) is a non-profit charity dedicated to obtaining funding for

independent research into the cause, treatment and prevention of autism and

other autoimmune disorders. Please visit our new website at

http://www.TAAP.info and " TAAP into the Truth! "